Literature DB >> 17917325

Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.

Tomoyuki Iwasaki1, Masato Yoneda, Atsushi Nakajima, Yasuo Terauchi.   

Abstract

OBJECTIVE: We investigated the association between the serum butyrylcholinesterase (BChE) activity and parameters of adiposity, insulin resistance and the serum lipid profile, including the serum levels of triglyceride (TG), HDL-cholesterol (HDL-C) and LDL-cholesterol (LDL-C) in Japanese patients with type 2 diabetes and non-diabetic subjects. PATIENTS AND METHODS: A total of 259 Japanese subjects [171 patients with type 2 diabetes (age 60.4+/-11.9 years, BMI 25.0+/-4.4) and 88 non-diabetic subjects (age 54.2+/-15.0 years, BMI 25.8+/-4.7)] were enrolled in the study. To assess the hepatic fat content, the ratio of the CT attenuation value of the liver to that of the spleen (L/S ratio) was calculated.
RESULTS: Serum BChE activity was significantly correlated with various indices of adiposity, including the waist circumference, L/S ratio, visceral fat area (VFA), subcutaneous fat area (SFA) and BMI, and also with the TG, HDL-C, LDL-C and HOMA-R, in the entire subject population. Even after adjustment for five variables, namely, age, gender, HbA1c, CRP and serum ferritin (the serum levels of ferritin and CRP have been reported to be associated with adiposity and insulin resistance), the serum BChE activity was still correlated with the waist circumference, L/S ratio, VFA, SFA, BMI, TG, HDL-C, LDL-C and HOMA-R. Furthermore, changes in the serum BChE activity were associated with changes in the L/S ratio, VFA and SFA at 1 year after the baseline.
CONCLUSIONS: These results indicate that the serum BChE activity is associated with parameters of adiposity, the serum lipid profile and the degree of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917325     DOI: 10.2169/internalmedicine.46.0049

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  37 in total

1.  Nongradient blue native gel analysis of serum proteins and in-gel detection of serum esterase activities.

Authors:  Nopporn Thangthaeng; Nathalie Sumien; Michael J Forster; Ruchir A Shah; Liang-Jun Yan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-31       Impact factor: 3.205

Review 2.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

3.  GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.

Authors:  Beben Benyamin; Rita P Middelberg; Penelope A Lind; Anne M Valle; Scott Gordon; Dale R Nyholt; Sarah E Medland; Anjali K Henders; Andrew C Heath; Pamela A F Madden; Peter M Visscher; Daniel T O'Connor; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-08-23       Impact factor: 6.150

4.  Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Michael B Stout; Michael D Jensen; Stephen Brimijoin
Journal:  Endocrinology       Date:  2016-06-14       Impact factor: 4.736

5.  Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community.

Authors:  Veronica Gonzalez; Karen Huen; Subha Venkat; Kelly Pratt; Pin Xiang; Kim G Harley; Katherine Kogut; Celina M Trujillo; Asa Bradman; Brenda Eskenazi; Nina T Holland
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-07-04       Impact factor: 5.563

Review 6.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

7.  Butyrylcholinesterase gene transfer in obese mice prevents postdieting body weight rebound by suppressing ghrelin signaling.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Stephen Brimijoin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 8.  Ghrelin and liver disease.

Authors:  Mar Quiñones; Johan Fernø; Omar Al-Massadi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 9.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.

Authors:  Judes Poirier; Justin Miron; Cynthia Picard; Patrick Gormley; Louise Théroux; John Breitner; Doris Dea
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

10.  Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.

Authors:  Marijana Radonjic; Jorn R de Haan; Marjan J van Erk; Ko Willems van Dijk; Sjoerd A A van den Berg; Philip J de Groot; Michael Müller; Ben van Ommen
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.